KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)
CUSIP: 483497103
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 50,580,036
- Total 13F shares
- 48,412,221
- Share change
- +87,998
- Total reported value
- $560,958,769
- Put/Call ratio
- 22%
- Price per share
- $11.58
- Number of holders
- 120
- Value change
- +$549,019
- Number of buys
- 63
- Number of sells
- 44
Quarterly Holders Quick Answers
What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 483497103:
Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VR Adviser, LLC |
13F
|
Company |
12%
|
6,249,731
|
$73,621,831 | — | 30 Jun 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
8.3%
|
4,218,829
|
$49,697,806 | — | 30 Jun 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
8.3%
|
4,192,005
|
$49,381,819 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
7.3%
|
3,687,867
|
$43,443,073 | — | 30 Jun 2024 | |
| Capital World Investors |
13F
|
Company |
6.4%
|
3,227,620
|
$38,021,364 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.8%
|
2,945,116
|
$34,693,467 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
4.5%
|
2,300,000
|
$27,094,000 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
4.1%
|
2,050,000
|
$24,149,000 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
1,990,588
|
$23,449,127 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
3.1%
|
1,590,000
|
$18,730,200 | — | 30 Jun 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
2.6%
|
1,338,568
|
$15,768,331 | — | 30 Jun 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
2.2%
|
1,128,478
|
$13,293,471 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
2.1%
|
1,059,540
|
$12,481,381 | — | 30 Jun 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
1.7%
|
881,937
|
$10,389,218 | — | 30 Jun 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
1.6%
|
806,973
|
$9,506,142 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
806,271
|
$9,499,311 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
756,430
|
$8,910,745 | — | 30 Jun 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
1.5%
|
736,765
|
$8,679,092 | — | 30 Jun 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.3%
|
643,897
|
$7,585,107 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
560,883
|
$6,607,202 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
535,717
|
$6,310,746 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
534,979
|
$6,302,535 | — | 30 Jun 2024 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
1%
|
529,365
|
$6,235,920 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.99%
|
500,000
|
$5,890,000 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.93%
|
467,998
|
$5,513,016 | — | 30 Jun 2024 | |
| Thomas Andrew Crockett |
3/4/5
|
CEO, Director |
—
mixed-class rows
|
322,315
mixed-class rows
|
$4,648,801 | — | 17 Feb 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.67%
|
338,584
|
$3,988,526 | — | 30 Jun 2024 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.67%
|
337,985
|
$3,981,463 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.66%
|
332,695
|
$3,919,147 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.57%
|
286,064
|
$3,369,833 | — | 30 Jun 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.43%
|
219,277
|
$2,583,083 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.42%
|
212,888
|
$2,507,820 | — | 30 Jun 2024 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.36%
|
184,358
|
$2,171,737 | — | 30 Jun 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.35%
|
175,000
|
$2,061,500 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.3%
|
150,462
|
$1,772,442 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
135,600
|
$1,597,367 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.26%
|
131,300
|
$1,546,714 | — | 30 Jun 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.24%
|
122,960
|
$1,448,469 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
110,594
|
$1,302,797 | — | 30 Jun 2024 | |
| Edward P. Feener |
3/4/5
|
CHIEF SCIENTIFIC OFFICER |
—
mixed-class rows
|
102,024
mixed-class rows
|
$1,200,262 | — | 17 May 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.2%
|
100,061
|
$1,178,719 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.17%
|
84,023
|
$989,791 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.16%
|
80,443
|
$947,618 | — | 30 Jun 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.16%
|
78,682
|
$926,873 | — | 30 Jun 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.14%
|
68,526
|
$807,236 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
63,122
|
$743,577 | — | 30 Jun 2024 | |
| Zimmer Partners, LP |
13F
|
Company |
0.12%
|
62,704
|
$738,653 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
62,507
|
$736,332 | — | 30 Jun 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.12%
|
60,755
|
$715,694 | — | 30 Jun 2024 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.11%
|
57,096
|
$672,591 | — | 30 Jun 2024 |
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q3 2024
As of 30 Sep 2024,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,412,221 shares.
The largest 10 holders included
VR Adviser, LLC, TANG CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Vestal Point Capital, LP, Frazier Life Sciences Management, L.P., Capital World Investors, BlackRock, Inc., VANGUARD GROUP INC, Boxer Capital, LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
120
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
118
Q3 2024 holders
120
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.